In 150 opioid-naïve adults with cancer starting oral morphine, open-label prophylactic dexamethasone vs no prophylaxis lowered mean nausea severity (Day 1: 1.36 vs 2.93; Day 5: 0.74 vs 1.53 on 0–10 scale); NNT 5 on Day 1. No serious adverse events.
RCTn = 150
Sulfiker et al. Prophylactic dexamethasone for prevention of opioid-induced nausea and vomiting in cancer patients: a randomised controlled trial (DEX-OINV Trial)